Abstract
Gelonin, purified from the seeds of Gelonium multiflorum, using cation-exchange and gel-filtration chromatography was characterised for its purity, homogeneity and molecular weight by reverse-phase HPLC (RP-HPLC) and SDS-PAGE analysis. The HPLC purified gelonin was used for entrapment studies in the liposomes. Liposomes were prepared by reverse phase evaporation (REV) technique using three different types of lipid composition in the same molar ratio. The method resulted in 75–80% entrapment efficiency of gelonin in the liposomes. Entrapped and unentrapped gelonin was characterized for physico-chemical, immunochemical and biological properties. The immunoreactivity of entrapped gelonin was fully preserved but the ribosome-inactivating property was slightly inhibited. The method involved mild conditions, highly reproducible and the liposomes produced appeared to be stable for several months. It has important implications in the development of cell type specific cytotoxic agents where a chemical cross-linking is involved which significantly inhibits both immunoreactivity and ribosome-inactivating ability of the toxin.
Similar content being viewed by others
References
Stripe F, Barbieri L: Ribosome-inactivating proteins up to date. FEBS Lett 195: 1–8, 1986
Barbieri L, Stripe F: Ribosome-inactivating proteins from plants: Properties and possible uses. Cancer Survey 1: 489–520, 1982
Lambert JM, Senter PD, Yao-Young A, Blattler WA, Goldmacher VS: Purified immunotoxins that are reactive with human lymphoid cells: Monoclonal antibodies conjugated to the ribosome inactivating proteins, gelonin and pokeweed antiviral proteins. J Biol Chem 260: 12035–12041, 1985
Scott CF Jr, Goldmacher VS, Lambert JM, Jacson SV, McIntyre GD: An immunotoxin composed of a monoclonal anti-transferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: Potent in vitro and in vivo effects against human tumors. J Natl Cancer Inst 79: 1163–1172, 1987
Laserman LD, Weinstein JN, Blumenthal R, Terry WD: Receptor mediated endocytosis of antibody-opsonized liposomes by tumor cells. Proc Natl Acad Sci USA 77: 4089–4093, 1980
Laserman LD, Barbet J, Kourilsky F, Weinstein JN: Targeting to cells of a fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature (London) 288: 602–604, 1980
Yosiyuki H, Hiroo E, Mnoru S: Liposome technology (Ed. Gregoriadis G) CRC Press, Vol 111: 42–50, 1986
Barbet J, Machy P, Laserman LD: Monoclonal antibody covalently coupled to liposome specific targeting to cells. J Suprmol Struct Cell Biochem 16: 243–268, 1981
Christopher J K, Gregoriadis G: Liposome technology (Ed. Gregoriadis G) CRC Press, Vol I: 20–28, 1986
Szoka F, Paphadjopoulas D: Procedure for separation of liposomes with large internal aqueous space and high capture of reverse-phase evaporation. Proc Natl Acad Sci USA 75: 4194–4198, 1978
Deamer DW, Bangham AD: Large volume of liposomes by an ether vaporisation method. Biochem Biophys Acta 443: 629–634, 1976
Kagewa Y, Racker E: Partial resolution of enzyme catalysing oxidative phosphorylation. XXV. Reconstitution of vesicles and catalysing 32Pi-ATP exchange. J Biol Chem 246: 5477–5487, 1971
Pick U: Liposome with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch Biochem Biophys 212: 186–194, 1981
Kirby CJ, Gregoriadis G: Incorporation of factor VIII into liposomes. In: G Gregoriadis (ed.) Liposome Technology. CRC Press, 1984
Singleton WS, Grey MS, Brown ML, White JL: Chromatographically homogeneous lecithin from egg phospholipids. J Am Oil Soc 42: 53–56, 1965
Stripe F, Olsnes S, Phil A: Gelonin, a new inhibitor of protein synthesis, non toxic to intact cells: Isolation, characterization and preparation of cytotoxic complexes with Concanavalin A. J Biol Chem 255: 6947–6953, 1980
Singh V, Sairam MR: Effect of thiolation on the immunoreactivity of the ribosome-inactivating protein gelonin. Biochem J 263: 417–423, 1989
Laemmli UK: Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature (London) 227: 680–685, 1970
Singh V, Sairam MR, Bhargavi GN, Akhras RG: Hormonotoxins. J Biol Chem 264: 3089–3095, 1989
Fraley R, Subramani S, Berg P, Papahajopoulous D: Introduction of liposome encapsulated SV40 DNA into cells. J Biol Chem 255: 10431–10435, 1990
Dancey GF, Yasuda T, Kinsky SC: Effect of liposomal modal membrane composition in immunology. J Immunol 120: 1109–1113, 1978
Bernstein SC: Biology of the laboratory mouse. EL Green (ed.). McGraw-Hill, N.Y., 2nd Ed. 344, 1966
Van Houte AJ, Snippe H, Schmitz MGJ, Willers JMN: Characterization of immunogenic properties of haptenated liposomal modal membrane in mouse. V. Effect of membrane composition on humoral and cellular immunogenecity. Immunology 44: 561–568, 1981
Thorpe PE, Edward DC, Ross WC: Antibody-toxin conjugates-aiming the magic bulet. In: J Fabre, A McMichael (eds) Monoclonal Antibodies in Clinical Medicine. Academic Press, London, 1982, pp 167–201
Olsnes S, Phil A: Chimeric toxins. Pharmacol Ther 15: 355–381, 1982
Vitteta ES, Krolick KK, Miyama-Inaba M, Cushely W, Uhr JW: Immunotoxin: A new approach to cancer therapy. Science 219: 644–650, 1984
Thorpe PE: Antibody carriers of cytotoxic agents in cancer therapy: A review. In: A Pinchera, G Doria, F Damacco, A Bargellesi (eds) Monoclonal Antibodies 84: Biological and Clinical Applications. Editrice Kurtis s. r. e., Milan, 1985, pp 475–512
Singh V, Sairam MR: Hormonotoxins: I. Strategy for synthesis of ovine leutenizing hormone-gelonin conjugate bearing toxin in the β-subunit. Int J Peptide and Protein Res 33: 22–28, 1989
Singh V, Sairam MR: Hormonotoxins: Conjugation of human chorionic gonadotropin with the ribosome inactivating protein gelonin and comparison with a lutropin conjugate. Mol Cell Endocrinol 67: 217–229, 1989
Singh V, Sairam MR: Hormonotoxins: Effect of modifying the gonadotropin α-subunit on the generation of lutropin-toxin conjugate. Int J Peptide and Protein Res 35: 46–51, 1990
Singh V, Das C: In vitro selective killing of gonadal tumor cells by a hormonotoxin composed of ovine luteinizing hormone linked by a disulfide bond to a ribosome-inactivating protein gelonin. Biochem Int 24: 689–699, 1991
Singh V: Design and synthesis of bioeffective hormonotoxins for selective elimination of gonadal cells. In: M Maggi, V Geenen (ed) Horizons in Endocrinology, Vol II, Serono Symposia Publications, Raven Press, Vol 76, 1991, pp 197–202
Singh V: Hormonotoxins: Synthesis, characterization and bioefficacy of some defined disulfide linked conjugates of ovine luteinizing hormone with a ribosome-inactivating protein gelonin. Indian J Exp Biol 29: 916–925, 1991
Singh V: Hormonotoxins. In: C Das, J Sengupta (eds) Recent Frontiers in Reproduction Research. Wiley-Eastern Publishers, New Delhi, India, 1992, in press.
Singh V, Kar SK: Properties of a ribosome-inactivating protein, purified from three different methods. Indian J Biochem Biophys 29: 31–41, 1992
Singh V: Effect of thiolation of amino groups of gelonin on its protein-biosynthesis inhibitor activity. Biochem Int 24: 677–688, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alam, A., Bhuri, S.R.K., Mavila, A.K. et al. Design of liposome to improve encapsulation efficiency of gelonin and its effect on immunoreactivity and ribosome inactivating property. Mol Cell Biochem 112, 97–109 (1992). https://doi.org/10.1007/BF00227566
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00227566